Filing Details

Accession Number:
0001140361-11-002888
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-01-14 12:45:35
Reporting Period:
2011-01-12
Filing Date:
2011-01-14
Accepted Time:
2011-01-14 12:45:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1107421 Ziopharm Oncology Inc ZIOP Services-Specialty Outpatient Facilities, Nec (8093) 841475642
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1091823 J Randal Kirk C/O Third Security, Llc
1881 Grove Avenue
Radford VA 24141
Yes No Yes No
1356090 Intrexon Corp C/O Legal Department
20358 Seneca Meadows Parkway
Germantown MD 20876
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-01-12 25,000 $0.00 25,000 No 4 A Direct
Common Shares Acquisiton 2011-01-12 2,426,235 $4.80 2,426,235 No 4 P Indirect By Intrexon Corporation
Common Stock Acquisiton 2011-01-12 3,636,926 $0.00 6,063,161 No 4 P Indirect By Intrexon Corporation
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 P Indirect By Intrexon Corporation
No 4 P Indirect By Intrexon Corporation
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to Purchase Common Stock Acquisiton 2011-01-12 25,000 $0.00 25,000 $5.21
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,000 2021-01-12 No 4 A Direct
Footnotes
  1. All restrictions related to the grant of restricted stock will lapse on January 12, 2012.
  2. Randal J. Kirk, directly and through certain affiliates, has voting and dispositive power over a majority of the outstanding capital stock of Intrexon Corporation. Mr. Kirk may therefore be deemed to have voting and dispositive power over the shares of the issuer owned by Intrexon Corporation. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
  3. Shares were issued as partial consideration in connection with the execution of an Exclusive Channel Partner Agreement dated January 6, 2011 between the issuer and Intrexon Corporation.
  4. Option to purchase shares of common stock will vest over a three (3) year period as follows: 8,334 shares on January 12, 2012; 8,333 shares on January 12, 2013; and 8,333 shares on January 12, 2014.